These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2317279)

  • 1. Effects of systemic atropine sulfate administration on the frequency content of the cat sensorimotor EEG during sleep and waking.
    Szymusiak R; McGinty D; Shouse MN; Shepard D; Sterman MB
    Behav Neurosci; 1990 Feb; 104(1):217-25. PubMed ID: 2317279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EEG dissociation induced by muscarinic receptor antagonists: Coherent 40 Hz oscillations in a background of slow waves and spindles.
    Castro-Zaballa S; Cavelli M; González J; Monti J; Falconi A; Torterolo P
    Behav Brain Res; 2019 Feb; 359():28-37. PubMed ID: 30321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study on the behavioral and EEG changes induced by diazepam, buspirone and a novel anxioselective anxiolytic, DN-2327, in the cat.
    Hashimoto T; Hamada C; Wada T; Fukuda N
    Neuropsychobiology; 1992; 26(1-2):89-99. PubMed ID: 1361973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counterpointing the functional role of the forebrain and of the brainstem in the control of the sleep-waking system.
    Villablanca JR
    J Sleep Res; 2004 Sep; 13(3):179-208. PubMed ID: 15339255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
    Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
    J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral, sleep-waking and EEG power spectral effects following the two specific 5-HT uptake inhibitors zimeldine and alaproclate in cats.
    Sommerfelt L; Ursin R
    Behav Brain Res; 1991 Nov; 45(2):105-15. PubMed ID: 1838688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atropine effects on the intermediate stage and paradoxical sleep in rats.
    Arnaud C; Gauthier P; Gottesmann C
    Psychopharmacology (Berl); 1994 Nov; 116(3):304-8. PubMed ID: 7892420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The action of lithium carbonate on the sleep-waking cycle in the cat.
    Lanoir J; Lardennois D
    Electroencephalogr Clin Neurophysiol; 1977 May; 42(5):676-90. PubMed ID: 67027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep/waking and EEG power spectrum effects of a nonselective serotonin (5-HT) antagonist and a selective 5-HT reuptake inhibitor given alone and in combination.
    Bjorvatn B; Bjørkum AA; Neckelmann D; Ursin R
    Sleep; 1995 Jul; 18(6):451-62. PubMed ID: 7481417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the selective alpha 1-adrenoceptor blocker prazosin on EEG sleep and waking stages in the rat.
    Kleinlogel H
    Neuropsychobiology; 1989; 21(2):100-3. PubMed ID: 2559357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide-S evoked arousal with electroencephalogram slow-wave compensatory drive in rats.
    Ahnaou A; Drinkenburg WH
    Neuropsychobiology; 2012 Jun; 65(4):195-205. PubMed ID: 22538299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GABAA receptor agonist THIP alters the EEG in waking and sleep of mice.
    Vyazovskiy VV; Kopp C; Bösch G; Tobler I
    Neuropharmacology; 2005 Apr; 48(5):617-26. PubMed ID: 15814097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased waking as well as increased synchronization following administration of selective 5-HT uptake inhibitors to rats.
    Ursin R; Bjorvatn B; Sommerfelt L; Underland G
    Behav Brain Res; 1989 Aug; 34(1-2):117-30. PubMed ID: 2527519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High doses of systemic DHEA-sulfate do not affect sleep structure and elicit moderate changes in non-REM sleep EEG in rats.
    Schiffelholz T; Holsboer F; Lancel M
    Physiol Behav; 2000 Jun 1-15; 69(4-5):399-404. PubMed ID: 10913777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of phenelzine treatment on EEG topography in waking and sleep in depressed patients.
    Landolt HP; Gillin JC
    Neuropsychopharmacology; 2002 Sep; 27(3):462-9. PubMed ID: 12225703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective group mGlu2/3 receptor agonist LY379268 suppresses REM sleep and fast EEG in the rat.
    Feinberg I; Campbell IG; Schoepp DD; Anderson K
    Pharmacol Biochem Behav; 2002 Sep; 73(2):467-74. PubMed ID: 12117602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lesion of descending 5-HT pathways increases zimeldine-induced waking in rats.
    Bjørkum AA; Neckelmann D; Bjorvatn B; Ursin R
    Physiol Behav; 1995 May; 57(5):959-66. PubMed ID: 7610150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Power spectral analysis of EEG activity obtained from cortical and subcortical sites during the vigilance states of the cat.
    Bronzino JD; Stern WC; Leahy JP; Morgane PJ
    Brain Res Bull; 1976; 1(3):285-94. PubMed ID: 184886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-frequency gamma electroencephalogram activity in association with sleep-wake states and spontaneous behaviors in the rat.
    Maloney KJ; Cape EG; Gotman J; Jones BE
    Neuroscience; 1997 Jan; 76(2):541-55. PubMed ID: 9015337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citalopram: differential sleep/wake and EEG power spectrum effects after single dose and chronic administration.
    Neckelmann D; Bjorvatn B; Bjørkum AA; Ursin R
    Behav Brain Res; 1996 Sep; 79(1-2):183-92. PubMed ID: 8883829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.